Sep 26 2020
Jazz Pharmaceuticals announces a new collaborative relationship with the American Heart Association to address heart disease in sleep disorders.
Posted at Sep 26 2020
h in News
h in News
Jazz Pharmaceuticals announces a new collaborative relationship with the American Heart Association to address heart disease in sleep disorders.
DUBLIN, Sept. 15, 2020 /PRNewswire/ — Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced its support of the American Heart Association’s sleep health educational content aimed at improving the health and well-being of those struggling with healthy sleep or those living with sleep disorders. As part of the initiative, the Association, with financial support from Jazz, will create educational multimedia content that will be available at www.heart.org/en/health-topics/sleep-disorders.